You have 9 free searches left this month | for more free features.

(11C)NNC-112

Showing 1 - 25 of 5,187

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Functional Relevance of Dopamine Receptors in Healthy Controls

Recruiting
  • Schizoaffective Disorder
  • Schizophrenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Hyperkalemia Trial in Worldwide (Patiromer, Placebos)

    Completed
    • Hyperkalemia
    • Alexander City, Alabama
    • +414 more
    Jan 11, 2022

    Thymic Epithelial Tumor, Recurrent Thymoma, Thymic Cancer Trial run by the NCI (PT-112)

    Recruiting
    • Thymic Epithelial Tumor
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita Trial in London (IMP Application KM-001, Physical Examination,

    Recruiting
    • Punctate Palmoplantar Keratoderma Type 1
    • Pachyonychia Congenita
    • IMP Application KM-001
    • +14 more
    • London, Whitechapel Rd, United Kingdom
      Royal London Hospital-Clinical Research Facility-11D (11th Floor
    Jul 23, 2023

    Parkinson's Disease, Multiple System Atrophy, Dementia With Lewy Bodies Trial (C11-SY08)

    Not yet recruiting
    • Parkinson's Disease
    • +3 more
    • (no location specified)
    Oct 24, 2023

    Acetoacetate and Acetate Metabolism in Chronic Kidney

    Not yet recruiting
    • Kidney Failure, Chronic
    • PET scan metabolic day
    • (no location specified)
    Jul 20, 2023

    ABPA Trial in Scottsdale, Santa Monica, Tampa (Itraconazole Powder, Placebo)

    Recruiting
    • ABPA
    • Itraconazole Powder
    • Placebo
    • Scottsdale, Arizona
    • +2 more
    Feb 1, 2023

    Phantom Limb Pain, Pain, Chronic Trial in Medellin (Epidural catheter, Continuous sciatic nerve block)

    Not yet recruiting
    • Phantom Limb Pain
    • Pain, Chronic
    • Epidural catheter
    • Continuous sciatic nerve block
    • Medellin, Colombia
      Antioquia´s University
    Nov 2, 2022

    ALS Trial ([11C]CPPC PET ligand)

    Not yet recruiting
    • ALS
    • [11C]CPPC PET ligand
    • (no location specified)
    Jan 9, 2023

    Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))

    Not yet recruiting
    • Muscarinic Receptor Occupancy
    • New Haven, Connecticut
      Yale University
    Aug 31, 2023

    Inflammation in Alzheimer's Disease and Related Dementias Using

    Recruiting
    • Alzheimer Disease
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 9, 2023

    Lung in Pulmonary Artery Hypertension (PAH)

    Not yet recruiting
    • Pulmonary Arterial Hypertension
    • Healthy
    • TSPO PET scan (11C-PBR28)
    • (no location specified)
    Feb 16, 2023

    Ketoses, Metabolic Trial (Observational heart and kidney on siemens TEP scan)

    Completed
    • Ketoses, Metabolic
    • Observational heart and kidney on siemens TEP scan
    • Sherbrooke, Quebec, Canada
      Research Center on Aging
    Jan 16, 2023

    Behavior, Health Trial in New Haven (Radiotracer)

    Recruiting
    • Behavior, Health
    • New Haven, Connecticut
      Yale University PET Center
    Jun 13, 2022

    Diabetic Retinopathy Trial in Puerto Rico, United States (Aflibercept Injection)

    Recruiting
    • Diabetic Retinopathy
    • Aflibercept Injection
    • Beverly Hills, California
    • +13 more
    Jan 6, 2022

    Tobacco Smoking, Nicotine Dependence Trial in United States (Very Low Nicotine Content Cigarettes, Normal Nicotine Content

    Completed
    • Tobacco Smoking
    • Nicotine Dependence
    • Very Low Nicotine Content Cigarettes
    • Normal Nicotine Content Cigarettes
    • San Francisco, California
    • +5 more
    Jan 17, 2023

    Atopic Dermatitis Trial in Seoul (NCP112)

    Completed
    • Atopic Dermatitis
    • Seoul, Korea, Republic of
      Severance Hospital
    Dec 15, 2022

    Systemic Lupus Erythematosus, Rheumatoid Arthritis Trial in United States (PF-06835375, Placebo)

    Completed
    • Systemic Lupus Erythematosus
    • Rheumatoid Arthritis
    • Anniston, Alabama
    • +17 more
    Apr 6, 2022

    MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)

    Not yet recruiting
    • Major Depressive Disorder
    • Toludesvenlafaxine hydrochloride sustained-release tablets
    • Shanghai, Shanghai, China
      Shanghai Mental Health Center
    Sep 7, 2023

    Healthy Volunteers - Liver Diseases Trial in Watford (NNC0560-0004, Placebo (NNC0560-0004))

    Recruiting
    • Healthy Volunteers - Liver Diseases
    • Watford, Middlesex, United Kingdom
      Novo Nordisk Investigational Site
    Nov 14, 2023

    Diabetes, Diabetes, Type 1 Trial in Worldwide (NNC0114-0006, liraglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • La Jolla, California
    • +107 more
    Mar 10, 2021

    Obesity, Overweight Trial in San Antonio (NNC0487-0111, Placebo (NNC0487-0111))

    Recruiting
    • Obesity
    • Overweight
    • San Antonio, Texas
      Novo Nordisk Investigational Site
    Sep 28, 2023

    Healthy Volunteers Trial in Solna ([11C]AZ14132516)

    Not yet recruiting
    • Healthy Volunteers
    • Solna, Sweden
      Research Site
    Apr 17, 2023

    Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.

    Not yet recruiting
    • Huntington Disease
    • [11C]UCB-J
    • [18F]SynVest-1
    • Leuven, Belgium
      UZ Leuven
    Nov 2, 2022

    Dopaminergic Transporter Density (DAT) in Obese Women

    Recruiting
    • Obesity
    • SPECT TRODAT-1
    • Ribeirão Preto, São Paulo, Brazil
      Clinical Hospital of Ribeirão Preto Medical School
    Mar 23, 2021